BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

759 related articles for article (PubMed ID: 17688884)

  • 1. Clinical significance of ghrelin concentration of plasma and tumor tissue in patients with gastric cancer.
    An JY; Choi MG; Noh JH; Sohn TS; Jin DK; Kim S
    J Surg Res; 2007 Dec; 143(2):344-9. PubMed ID: 17688884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The overexpression of c-met as a prognostic indicator for gastric carcinoma compared to p53 and p21 nuclear accumulation.
    Drebber U; Baldus SE; Nolden B; Grass G; Bollschweiler E; Dienes HP; Hölscher AH; Mönig SP
    Oncol Rep; 2008 Jun; 19(6):1477-83. PubMed ID: 18497953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Role of duodenum in regulation of plasma ghrelin level and body mass index after subtotal gastrectomy].
    Wang HT; Lu QC; Wang Q; Wang RC; Zhang Y; Chen HL; Qian HX
    Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Sep; 11(5):436-9. PubMed ID: 18803044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postoperative ghrelin levels and delayed recovery from body weight loss after distal or total gastrectomy.
    Takachi K; Doki Y; Ishikawa O; Miyashiro I; Sasaki Y; Ohigashi H; Murata K; Nakajima H; Hosoda H; Kangawa K; Sasakuma F; Imaoka S
    J Surg Res; 2006 Jan; 130(1):1-7. PubMed ID: 16182310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of the eradication of Helicobacter pylori on gastric ghrelin, appetite, and body mass index in patients with peptic ulcer disease.
    Jang EJ; Park SW; Park JS; Park SJ; Hahm KB; Paik SY; Sin MK; Lee ES; Oh SW; Park CY; Baik HW
    J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S278-85. PubMed ID: 19120912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue factor expression is a clinical indicator of lymphatic metastasis and poor prognosis in gastric cancer with intestinal phenotype.
    Yamashita H; Kitayama J; Ishikawa M; Nagawa H
    J Surg Oncol; 2007 Mar; 95(4):324-31. PubMed ID: 17066404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positive peritoneal washing cytology in multiple cavities can predict poor prognosis of advanced gastric cancer patients.
    Homma Y; Ushida S; Yamada M; Kobayashi H; Suzuki K
    Ann Surg Oncol; 2010 Feb; 17(2):455-60. PubMed ID: 19847567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical alterations from normal mucosa to gastric cancer by ex vivo magnetic resonance spectroscopy.
    Calabrese C; Pisi A; Di Febo G; Liguori G; Filippini G; Cervellera M; Righi V; Lucchi P; Mucci A; Schenetti L; Tonini V; Tosi MR; Tugnoli V
    Cancer Epidemiol Biomarkers Prev; 2008 Jun; 17(6):1386-95. PubMed ID: 18559553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple early gastric cancer with gastritis cystica profunda showing various histological types.
    Tsuji T; Iwahashi M; Nakamori M; Ueda K; Ishida K; Naka T; Ojima T; Akamatsu H; Yamaue H
    Hepatogastroenterology; 2008; 55(84):1150-2. PubMed ID: 18705349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression levels of cyclin G2, but not cyclin E, correlate with gastric cancer progression.
    Choi MG; Noh JH; An JY; Hong SK; Park SB; Baik YH; Kim KM; Sohn TS; Kim S
    J Surg Res; 2009 Dec; 157(2):168-74. PubMed ID: 19559447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality-of-life after curative surgery for gastric cancer: a comparison between total gastrectomy and subtotal gastric resection.
    Jentschura D; Winkler M; Strohmeier N; Rumstadt B; Hagmüller E
    Hepatogastroenterology; 1997; 44(16):1137-42. PubMed ID: 9261613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-level expression of S100A4 correlates with lymph node metastasis and poor prognosis in patients with gastric cancer.
    Wang YY; Ye ZY; Zhao ZS; Tao HQ; Chu YQ
    Ann Surg Oncol; 2010 Jan; 17(1):89-97. PubMed ID: 19820999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for lymph node metastasis in histologically poorly differentiated type early gastric cancer.
    Kunisaki C; Takahashi M; Nagahori Y; Fukushima T; Makino H; Takagawa R; Kosaka T; Ono HA; Akiyama H; Moriwaki Y; Nakano A
    Endoscopy; 2009 Jun; 41(6):498-503. PubMed ID: 19533552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Influence of digestive tract reconstruction techniques on plasma ghrelin level and body mass index after subtotal gastrectomy].
    Wang HT; Xu J; Wang RC; Zhang Y; Lu QC
    Zhonghua Wei Chang Wai Ke Za Zhi; 2011 Jun; 14(6):425-7. PubMed ID: 21713701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IGF-1 and IGF-1BP3 in gastric adenocarcinoma. Preliminary study.
    Franciosi CM; Piacentini MG; Conti M; Romano F; Musco F; Caprotti R; Rovelli F; Uggeri F
    Hepatogastroenterology; 2003; 50(49):297-300. PubMed ID: 12630045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological, histological, and clinical impact of preoperative IL-2 administration in radically operable gastric cancer patients.
    Romano F; Cesana G; Berselli M; Gaia Piacentini M; Caprotti R; Bovo G; Uggeri F
    J Surg Oncol; 2004 Dec; 88(4):240-7. PubMed ID: 15565596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of ADAM17 expression in patients with gastric cancer who underwent curative gastrectomy.
    Aydin D; Bilici A; Yavuzer D; Kefeli U; Tan A; Ercelep O; Mert A; Yuksel S; Ozcelik M; Isik D; Surmeli H; Odabasi H; Aliustaoglu M
    Clin Transl Oncol; 2015 Aug; 17(8):604-11. PubMed ID: 25786367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastric inhibitory polypeptide appears less important in mediating acid secretion.
    Wang YY; Lee CT; Lu CL; Chen CY; Chang FY; Lee SD; Doong ML; Wang PS
    Hepatogastroenterology; 1999; 46(27):2105-9. PubMed ID: 10430406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of Fas ligand and sFas ligand in human gastric adenocarcinomas.
    Lim SC
    Oncol Rep; 2002; 9(1):103-7. PubMed ID: 11748465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of ghrelin administration after total gastrectomy: a prospective, randomized, placebo-controlled phase II study.
    Adachi S; Takiguchi S; Okada K; Yamamoto K; Yamasaki M; Miyata H; Nakajima K; Fujiwara Y; Hosoda H; Kangawa K; Mori M; Doki Y
    Gastroenterology; 2010 Apr; 138(4):1312-20. PubMed ID: 20060830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.